Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

TORRENT PHARMACEUTICALS LTD.

NSE : TORNTPHARMBSE : 500420ISIN CODE : INE685A01028Industry : Pharmaceuticals & DrugsHouse : Torrent

BSE4470.00-2.95 (-0.07 %)

PREV CLOSE ( ) 4472.95

OPEN PRICE ( ) 4494.65

BID PRICE (QTY) 4466.10 (21)

OFFER PRICE (QTY) 4470.85 (13)

VOLUME 11632

TODAY'S LOW / HIGH ( )4464.65 4560.00

52 WK LOW / HIGH ( )3139.5 4714.5

NSE4475.502.6 (+0.06 %)

PREV CLOSE( ) 4472.90

OPEN PRICE ( ) 4490.00

BID PRICE (QTY) 4472.40 (6)

OFFER PRICE (QTY) 4475.50 (23)

VOLUME 275267

TODAY'S LOW / HIGH( ) 4464.00 4560.10

52 WK LOW / HIGH ( )3140.1 4712.9

Quarters

Select year

( in Million)

Particulars

Mar 2026

Dec 2025

Sep 2025

Jun 2025

Audited / UnAudited

UnAudited

Net Sales

41970

33030

33020

31780

Total Expenditure

28410

22150

22190

21460

PBIDT (Excl OI)

13560

10880

10830

10320

Other Income

-170

-130

-270

-370

Operating Profit

13390

10750

10560

9950

Interest

2360

450

480

560

Exceptional Items

-660

-100

-130

PBDT

10370

10200

9950

9390

Depreciation

5080

2060

2040

2010

Profit Before Tax

5290

8140

7910

7380

Tax

1650

1790

2000

1900

Provisions and contingencies

Profit After Tax

3640

6350

5910

5480

Extraordinary Items

Prior Period Expenses

Other Adjustments

Net Profit

3640

6350

5910

5480

Minority Interest

250

Shares of Associates

Other related items

Misc. Expenses Written off

Consolidated Net Profit

3890

6350

5910

5480

Equity Capital

1692.3

Face Value (IN RS)

Reserves

Calculated EPS

11.49

18.76

17.46

16.19

Calculated EPS (Annualised)

45.97

75.04

69.84

64.76

No of Public Share Holdings

107260040

% of Public Share Holdings

31.69

PBIDTM% (Excl OI)

32.30

32.93

32.79

32.47

PBIDTM%

31.90

32.54

31.98

31.30

PBDTM%

24.70

30.88

30.13

29.54

PBTM%

12.60

24.64

23.95

23.22

PATM%

8.67

19.22

17.89

17.24

Notes

Risk Disclosures on Derivatives

Quarterly Results

TORRENT PHARMACEUTICALS LTD.